Ondansetron Tablet
Product Images NDC 69339-172

7 FDA label images from Natco Pharma Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 69339-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Ondansetron hydrochloride dihydrate showing its molecular arrangement with labeled atoms and bonds, consistent with the drug's active ingredient form.*
FDA Label Image

Label-30s (Ondansetron Tablets 4mg 30s)

Label-30s (Ondansetron Tablets 4mg 30s)
Ondansetron 4 mg oral tablets label by Natco Pharma USA LLC. The label indicates 30 film-coated tablets, prescription only. Storage instructions specify 20°-25°C, and the tablet contains ondansetron hydrochloride dihydrate equivalent to 4 mg ondansetron.*
FDA Label Image

Label-100s (Ondansetron 4mg 100s Label)

Label-100s (Ondansetron 4mg 100s Label)
Ondansetron Tablets USP 4 mg oral tablets packaging label. The label indicates a bottle containing 100 film-coated tablets with each tablet containing 4 mg of ondansetron. The label shows Natco Pharma USA LLC as the manufacturer and includes storage instructions, prescription-only status, and a barcode. The label also notes the product meets USP dissolution standards.*
FDA Label Image

Label-500s (Ondansetron Tablets 4mg 500s)

Label-500s (Ondansetron Tablets 4mg 500s)
Ondansetron Tablets, USP 4 mg oral tablets packaging label, showing 500 count. The label features the Natco Pharma USA LLC brand, instructions that each film-coated tablet contains 5 mg ondansetron hydrochloride dihydrate equivalent to 4 mg ondansetron, storage conditions, and dispensing information. The label includes NDC 69339-171-05 and barcodes, along with manufacturing details indicating Natco Pharma Limited, India, and Natco Pharma USA LLC.*
FDA Label Image

Label-30s (Ondansetron 8mg 30s)

Label-30s (Ondansetron 8mg 30s)
Label for Ondansetron Tablets USP 8 mg oral tablets, packaged 30 tablets per container. The label includes a depiction of a single oblong, beige tablet marked with an imprint. The product is manufactured by Natco Pharma Limited, India, and labeled for DASH Pharmaceuticals LLC, Upper Saddle River, NJ. Additional storage and handling instructions are provided.*
FDA Label Image

Label-100s (Ondansetron 8mg 100s Label)

Label-100s (Ondansetron 8mg 100s Label)
Ondansetron Tablets, USP 8 mg tablet blister pack label by Natco Pharma USA LLC. The label shows the product name, strength, quantity (100 tablets), and includes storage instructions, manufacturer details (Natco Pharma Limited, India and Natco Pharma USA LLC, Parsippany, NJ), and barcodes. It indicates Rx only status and tablet count.*
FDA Label Image

Label-500s (Ondansetron Tablets 8mg 500s)

Label-500s (Ondansetron Tablets 8mg 500s)
Ondansetron Tablets USP 8 mg oral tablets packaging label showing 500 tablets count. The label states the product contains 10 mg ondansetron hydrochloride dihydrate equivalent to 8 mg ondansetron per film-coated tablet. It includes storage instructions and mentions manufacturing by Natco Pharma Limited, India, for Natco Pharma USA LLC. The label features the Natco Pharma USA logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.